Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126455122 | 12645512 | 2 | F | 2016 | 20160811 | 20160811 | 20160819 | EXP | AU-SYMPLMED PHARMACEUTICALS-2016SYMPLMED000290 | SYMPLMED PHARMACEUTICALS | 0.00 | Y | 0.00000 | 20160819 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126455122 | 12645512 | 1 | PS | perindopril | PERINDOPRIL | 1 | Oral | 2.5 MG, QD | Y | U | UNKNOWN | 20184 | 2.5 | MG | TABLET | ||||
| 126455122 | 12645512 | 2 | SS | PF-04950615 VS Placebo | BOCOCIZUMAB | 1 | Subcutaneous | SUBCUTANEOUS ADMINISTRATION EVERY 2 WEEKS | UNKNOWN | 0 | |||||||||
| 126455122 | 12645512 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 80 MG, QD | U | UNKNOWN | 0 | 80 | MG | ||||||
| 126455122 | 12645512 | 4 | C | DABIGATRAN | DABIGATRAN | 1 | Oral | 110 MG, BID | U | UNKNOWN | 0 | 110 | MG | ||||||
| 126455122 | 12645512 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | U | UNKNOWN | 0 | 500 | MG | ||||||
| 126455122 | 12645512 | 6 | C | SAXAGLIPTIN | SAXAGLIPTIN | 1 | Oral | 5 MG, QD | U | UNKNOWN | 0 | 5 | MG | ||||||
| 126455122 | 12645512 | 7 | C | LOVAN | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, QD | U | UNKNOWN | 0 | 40 | MG | ||||||
| 126455122 | 12645512 | 8 | C | STILNOX | ZOLPIDEM TARTRATE | 1 | Oral | ONE TABLET, QD | U | UNKNOWN | 0 | ||||||||
| 126455122 | 12645512 | 9 | C | COLOXYL WITH SENNA | DOCUSATESENNOSIDES | 1 | Oral | 1 TABLET, QD | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126455122 | 12645512 | 1 | Hypertension |
| 126455122 | 12645512 | 2 | Cardiovascular disorder |
| 126455122 | 12645512 | 3 | Arteriosclerosis |
| 126455122 | 12645512 | 4 | Atrial fibrillation |
| 126455122 | 12645512 | 5 | Diabetes mellitus |
| 126455122 | 12645512 | 6 | Diabetes mellitus |
| 126455122 | 12645512 | 7 | Depression |
| 126455122 | 12645512 | 8 | Insomnia |
| 126455122 | 12645512 | 9 | Constipation prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126455122 | 12645512 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126455122 | 12645512 | Altered state of consciousness | |
| 126455122 | 12645512 | Atelectasis | |
| 126455122 | 12645512 | Clavicle fracture | |
| 126455122 | 12645512 | Fall | |
| 126455122 | 12645512 | Orthostatic hypotension | |
| 126455122 | 12645512 | Pneumonia | |
| 126455122 | 12645512 | Rash | |
| 126455122 | 12645512 | Renal impairment | |
| 126455122 | 12645512 | Rib fracture | |
| 126455122 | 12645512 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126455122 | 12645512 | 1 | 20150514 | 20160704 | 0 | |
| 126455122 | 12645512 | 2 | 20160528 | 0 | ||
| 126455122 | 12645512 | 3 | 20141106 | 0 | ||
| 126455122 | 12645512 | 4 | 20160201 | 0 | ||
| 126455122 | 12645512 | 5 | 2013 | 0 | ||
| 126455122 | 12645512 | 6 | 2015 | 0 | ||
| 126455122 | 12645512 | 7 | 2013 | 0 | ||
| 126455122 | 12645512 | 8 | 2015 | 0 | ||
| 126455122 | 12645512 | 9 | 2013 | 0 |